SCHEMBL5475178

SCHEMBL5475178

Cc1ccc2c(c1)C(O)(c1ccccc1)c1cc(C)ccc1O2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 2/20 0.38
OPRM1 P35372 2/20 0.37
OPRK1 P41145 2/20 0.37
OPRL1 P41146 2/20 0.37
AKR1B1 P15121 1/20 0.37
GAA P10253 2/20 0.36
LMNA P02545 3/20 0.36
MAPT P10636 2/20 0.35
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALOX12 P18054 1/20 0.35
P2RX1 P51575 1/20 0.35
P2RX3 P56373 1/20 0.35
P2RX4 Q99571 1/20 0.35
P2RX7 Q99572 1/20 0.35
KMT2A Q03164 1/20 0.35
CHRM3 P20309 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
MAOB P27338 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14363429 0.91 CHRNA1 (0.37) PDK2OPRM1OPRK1OPRL1AKR1B1
SCHEMBL12968939 0.82 PDK2 (0.42) PDK2OPRM1OPRK1OPRL1GAA
SCHEMBL5481314 0.81 TSHR (0.41) PDK2AKR1B1LMNAMAPTKDM4E
SCHEMBL5467986 0.79 GAA (0.36) PDK2AKR1B1GAALMNAMAPT
SCHEMBL5474650 0.79 CYP19A1 (0.35) GAALMNAMAPTALDH1A1P2RX1
SCHEMBL7322612 0.79 CHRM3 (0.45) PDK2OPRM1OPRK1OPRL1LMNA
SCHEMBL21309291 0.78 LMNA (0.36) PDK2GAALMNAKDM4EKMT2A
SCHEMBL7322189 0.78 LMNA (0.45) PDK2OPRM1OPRK1OPRL1GAA
SCHEMBL29722 0.77 CHRM3 (0.46) GAAP2RX1P2RX3P2RX4P2RX7
SCHEMBL20146658 0.77 LMNA (0.35) PDK2GAALMNAMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070276139-A1 Substituted Pixyl Protecting Groups for Oligonucleotide Synthesis ISIS PHARMACEUTICALS, INC. 2007-11-29 US disclosed
US-20070276139-A1 Substituted Pixyl Protecting Groups for Oligonucleotide Synthesis ISIS PHARMACEUTICALS, INC. 2007-11-29 US disclosed
US-20070276139-A1 Substituted Pixyl Protecting Groups for Oligonucleotide Synthesis ISIS PHARMACEUTICALS, INC. 2007-11-29 US disclosed
WO-2005077966-A1 SUBSTITUTED PIXYL PROTECTING GROUPS FOR OLIGONUCLEOTIDE SYNTHESIS ISIS PHARMACEUTICALS, INC. (US) 2005-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070276139-A1 Substituted Pixyl Protecting Groups for Oligonucleotide Synthesis RPP30, NOP10, NR0B1 PDK2 3896/4885OPRM1 272/4885OPRK1 197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.